EMBECTA CORP. Share-based Payment Arrangement, Expense, Tax Benefit
EMBECTA CORP. (EMBC) reported Share-based Payment Arrangement, Expense, Tax Benefit of $500.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-08-07
- EMBECTA CORP. share-based payment arrangement, expense, tax benefit for the quarter ending 2026-06-30 was $500.00K, a 44.44% decline year-over-year.
- EMBECTA CORP. share-based payment arrangement, expense, tax benefit for the quarter ending 2026-03-31 was $700.00K, a 30.00% decline year-over-year.
- EMBECTA CORP. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-12-31 was $800.00K, a 20.00% decline year-over-year.
- EMBECTA CORP. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-09-30 was $1.10M, a 21.43% decline year-over-year.
- EMBECTA CORP. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $4.20M, a 31.25% increase from fiscal 2024.
- EMBECTA CORP. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $3.20M, a 18.52% increase from fiscal 2023.
- EMBECTA CORP. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $2.70M, a 6.90% decline from fiscal 2022.
- EMBECTA CORP. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $2.90M, a 3.57% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 3 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $500.00K 10-Q · filed 2026-08-07 | $1.20M derived: sum of 2 quarters · filed 2026-08-07 | $2.00M 10-Q · filed 2026-08-07 | $3.10M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $700.00K 10-Q · filed 2026-05-05 | $1.50M 10-Q · filed 2026-05-05 | $2.60M derived: sum of 3 quarters · filed 2026-05-05 | $3.50M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $800.00K 10-Q · filed 2026-02-05 | $1.90M derived: sum of 2 quarters · filed 2026-02-05 | $2.80M derived: sum of 3 quarters · filed 2026-08-07 | $3.80M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-09-30 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $2.00M derived: sum of 2 quarters · filed 2026-08-07 | $3.00M derived: sum of 3 quarters · filed 2026-08-07 | $4.20M 10-K · filed 2025-11-25 | |
| 2025-06-30 | $900.00K 10-Q · filed 2026-08-07 | $1.90M derived: sum of 2 quarters · filed 2026-08-07 | $3.10M 10-Q · filed 2026-08-07 | $4.30M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $1.00M 10-Q · filed 2026-05-05 | $2.00M 10-Q · filed 2026-05-05 | $3.40M derived: sum of 3 quarters · filed 2026-05-05 | $4.00M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $1.00M 10-Q · filed 2026-02-05 | $2.40M derived: sum of 2 quarters · filed 2026-02-05 | $3.00M derived: sum of 3 quarters · filed 2026-02-05 | $3.50M derived: sum of 4 quarters · filed 2026-02-05 | |
| 2024-09-30 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $2.00M derived: sum of 2 quarters · filed 2025-11-25 | $2.50M derived: sum of 3 quarters · filed 2025-11-25 | $3.20M 10-K · filed 2025-11-25 | |
| 2024-06-30 | $600.00K 10-Q · filed 2025-08-08 | $1.10M derived: sum of 2 quarters · filed 2025-08-08 | $1.80M 10-Q · filed 2025-08-08 | $2.30M derived: sum of 4 quarters · filed 2025-11-25 | |
| 2024-03-31 | $500.00K 10-Q · filed 2025-05-09 | $1.20M 10-Q · filed 2025-05-09 | $1.70M derived: sum of 3 quarters · filed 2025-11-25 | $2.40M derived: sum of 4 quarters · filed 2025-11-25 | |
| 2023-12-31 | $700.00K 10-Q · filed 2025-02-06 | $1.20M derived: sum of 2 quarters · filed 2025-11-25 | $1.90M derived: sum of 3 quarters · filed 2025-11-25 | $2.60M derived: sum of 4 quarters · filed 2025-11-25 | |
| 2023-09-30 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $1.20M derived: sum of 2 quarters · filed 2025-11-25 | $1.90M derived: sum of 3 quarters · filed 2025-11-25 | $2.70M 10-K · filed 2025-11-25 | |
| 2023-06-30 | $700.00K 10-Q · filed 2024-08-09 | $1.40M derived: sum of 2 quarters · filed 2024-08-09 | $2.20M 10-Q · filed 2024-08-09 | $2.50M derived: sum of 4 quarters · filed 2024-12-11 | |
| 2023-03-31 | $700.00K 10-Q · filed 2024-05-09 | $1.50M 10-Q · filed 2024-05-09 | $1.80M derived: sum of 3 quarters · filed 2024-12-11 | $2.90M derived: sum of 4 quarters · filed 2024-12-11 | |
| 2022-12-31 | $1.30M 10-Q · filed 2024-02-09 | $800.00K 10-Q · filed 2023-02-14 | $1.10M derived: sum of 2 quarters · filed 2024-12-11 | $2.20M derived: sum of 3 quarters · filed 2024-12-11 | $3.20M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-09-30 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | $900.00K derived: sum of 2 quarters · filed 2024-12-11 | $1.90M derived: sum of 3 quarters · filed 2024-12-11 | $2.90M 10-K · filed 2024-12-11 | |
| 2022-06-30 | $1.10M 10-Q · filed 2023-08-08 | $2.10M derived: sum of 2 quarters · filed 2023-08-08 | $3.10M 10-Q · filed 2023-08-08 | $3.60M derived: sum of 4 quarters · filed 2023-11-29 | |
| 2022-03-31 | $1.00M 10-Q · filed 2023-05-12 | $2.00M 10-Q · filed 2023-05-12 | $2.50M derived: sum of 3 quarters · filed 2023-11-29 | $3.20M derived: sum of 4 quarters · filed 2023-11-29 | |
| 2021-12-31 | $1.00M 10-Q · filed 2023-02-14 | $1.50M derived: sum of 2 quarters · filed 2023-11-29 | $2.20M derived: sum of 3 quarters · filed 2023-11-29 | $2.90M derived: sum of 4 quarters · filed 2023-11-29 | |
| 2021-09-30 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | $1.20M derived: sum of 2 quarters · filed 2023-11-29 | $1.90M derived: sum of 3 quarters · filed 2023-11-29 | $2.80M 10-K · filed 2023-11-29 | |
| 2021-06-30 | $700.00K 10-Q · filed 2022-08-15 | $1.40M derived: sum of 2 quarters · filed 2022-08-15 | $2.30M 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $700.00K 10-Q · filed 2022-05-13 | $1.60M 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $900.00K 10-Q · filed 2022-03-16 | ||||
| 2020-09-30 | $3.00M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |